S Pigorsch
Overview
Explore the profile of S Pigorsch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
117
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hallqvist D, Kormann C, Pigorsch S, Kiechle M, Combs S, Habermehl D
Eur J Med Res
. 2024 Aug;
29(1):445.
PMID: 39217367
Purpose: For women with locoregionally advanced cervical cancer, the standard of care treatment is the curatively intended chemoradiation therapy (CRT). A relationship between bone marrow (BM) dose-volume histograms (DVHs) and...
2.
Borm K, Kessel K, Devecka M, Muench S, Straube C, Schiller K, et al.
Strahlenther Onkol
. 2019 Nov;
196(1):15-22.
PMID: 31722060
Purpose: Lymph node irradiation in breast cancer has gained complexity due to recently published studies and technical innovations which then led to changes in international guidelines. We sought to determine...
3.
Eder T, Hess A, Konschak R, Stromberger C, Johrens K, Fleischer V, et al.
Eur J Cancer
. 2019 Jun;
116:67-76.
PMID: 31173964
Background: Tumour mutational burden (TMB) estimated from whole exome sequencing or comprehensive gene panels has previously been established as predictive factor of response to immune checkpoint inhibitors (ICIs). Its predictive...
4.
Wendt T, Gademann G, Pambor C, von Specht H, Martin T, Baltas D, et al.
Strahlenther Onkol
. 2016 May;
180 Suppl 1:5-87.
PMID: 27137922
No abstract available.
5.
Tinhofer I, Budach V, Saki M, Konschak R, Niehr F, Johrens K, et al.
Eur J Cancer
. 2016 Feb;
57:78-86.
PMID: 26896955
Background: Despite clear differences in clinical presentation and outcome, squamous cell carcinomas of the head and neck (SCCHN) arising from human papilloma virus (HPV) infection or heavy tobacco/alcohol consumption are...
6.
Fakhrian K, Thamm R, Knapp S, Molls M, Pigorsch S, Haller B, et al.
Strahlenther Onkol
. 2011 Dec;
188(1):56-61.
PMID: 22189437
Purpose: The goal was to retrospectively review the outcome of patients with cervical lymph node metastases of squamuos cell carcinoma of unknown primary site (CUP) treated with radio(chemo)therapy. Patients And...
7.
Bache M, Pigorsch S, Dunst J, Wurl P, Meye A, Bartel F, et al.
Int J Cancer
. 2001 Apr;
96(2):110-7.
PMID: 11291094
We have examined the modulation of radiosensitivity by using caffeine in two human sarcoma cell lines both with a p53 mutation (US8-93 and LMS6-93). In both cell lines a strong...
8.
Dunst J, Semlin S, Pigorsch S, Muller A, Reese T
Strahlenther Onkol
. 2000 Oct;
176(9):416-21.
PMID: 11050915
Purpose: Amifostine has been shown to be able to reduce acute radiation toxicity if administered daily prior to radiation during a course of a conventionally fractionated radiotherapy. A disadvantage is...
9.
Dunst J, Pigorsch S, Hansgen G, Hintner I, Lautenschlager C, Becker A
Strahlenther Onkol
. 1999 Mar;
175(3):93-6.
PMID: 10093609
Background: Vascular endothelial growth factor (VEGF) is an endothelial cell specific mitogen with strong angiogenic activity. Expression of VEGF may therefore be an indicator for the angiogenic potential and biological...